Drug Approval | November 17, 2021
Alembic JV receives final approval for Mupirocin cream
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
It had an estimated market size of US $ 32 million as of June 2021
The US business faced price erosion due to increased competition.
The company has a cumulative total of 147 ANDA approvals (129 final approvals and 18 tentative approvals) from USFDA
Lurasidone Hydrochloride tablets are also indicated for adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder
Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Subscribe To Our Newsletter & Stay Updated
